ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress [Yahoo! Finance]
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price target raised by analysts at HC Wainwright from $13.00 to $16.00. They now have a "buy" rating on the stock.
Form 8-K Eledon Pharmaceuticals, For: May 06
Form 10-K/A Eledon Pharmaceuticals, For: Dec 31
Form 10-K Eledon Pharmaceuticals, For: Dec 31
Form 8-K Eledon Pharmaceuticals, For: Mar 28
Form SC 13G Eledon Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.